| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.8M | +64.1% | +697.1% |
| Cost of Revenue | $7.1M | +11.2% | +92.7% |
| Gross Profit | $738K | +146.1% | +127.4% |
| R&D Expense | $4.6M | +21.7% | +42.8% |
| SG&A Expense | $29.8M | +663.3% | +714.1% |
| Operating Income | -$34.4M | -248.4% | -223.2% |
| Net Income | -$33.8M | -264.6% | -194.3% |
| EPS (Basic) | -$0.26 | -271.4% | -85.7% |
| EPS (Diluted) | -$0.26 | -271.4% | -85.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $37.7M | -21.3% | +383.3% |
| Accounts Receivable | $7.8M | +86.5% | +642.5% |
| Inventory | $847K | +197.4% | +234.7% |
| Current Assets | $53.4M | -15.3% | +129.4% |
| Total Assets | $119.4M | -3.2% | +56.2% |
| Current Liabilities | $6.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.7M | — | — |
| Investing Cash Flow | -$9.7M | — | — |
| Financing Cash Flow | $55.4M | — | — |
| -38.1% |
| Long-term Debt | $2.1M | — | — |
| Total Liabilities | $6.7M | +52.9% | -38.5% |
| Stockholders' Equity | $112.8M | -5.2% | +71.9% |